Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
Sandel
Darrell C
DC
Wang
Cheng-Teng
CT
Kessler
Stuart
S
D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D004641:Emigration and Immigration; D004926:Escherichia coli / Q000187:drug effects* / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D009519:New York City / Q000453:epidemiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014505:Urban Population; D014552:Urinary Tract Infections / Q000382:microbiology*
D000892:Anti-Infective Agents, Urinary; D002939:Ciprofloxacin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination